It was a tug of war on Wall Street this Thursday as investors grappled with rising treasury yields and mixed corporate reports. The Dow Jones Industrial Average drifted lower, slipping about 0.1 percent, while the S&P 500 struggled to maintain its footing. Technical analysts noted that the S&P 500 dipped below its critical 50 day
President Trump has spent much of his second term boasting that his return to office ended the era of runaway egg prices, frequently pointing to the dramatic drop in costs as a victory for his administration. Federal data supports the claim that prices have plummeted, falling from an average of 4.95 dollars a dozen in
Walmart is turning its aisles into a high tech scavenger hunt to solve one of the oldest frustrations of big box shopping: finding a single item among 120,000 different products. The retail giant is expanding a series of tools linked to its digital shelf labels designed to guide both shoppers and staff toward specific items
The era of coffee badging, where employees would swipe their IDs and flee back home after a quick caffeine fix, is being replaced by a more calculated strategy known as calendar stalking. As companies double down on strict return to office mandates, workers are now obsessively monitoring their managers’ digital calendars to ensure their office
Mark Ruffalo did not hold back his frustration following a federal judge’s decision to greenlight the massive 110 billion dollar merger between Paramount and Warner Bros. Discovery. Taking to social media, the actor described the ruling as incredibly disappointing, claiming that the consolidation of these two entertainment giants will ultimately stifle artistic creativity and threaten
Eli Lilly is pushing the boundaries of weight loss science with its latest experimental medication, retatrutide, which has shown staggering results in recent clinical trials. According to data released during a medical conference in Europe and published in the journal Lancet, patients with type 2 diabetes taking the highest dose of the drug lost an
Eli Lilly is pushing the boundaries of metabolic medicine with a new combination therapy designed specifically for people battling both obesity and type 2 diabetes. The experimental drug, known as eloraTZP, combines the popular weight loss medication Zepbound with an amylin receptor agonist called eloralintide. In recent study results presented at the European Association for
A bitter public feud has erupted between two of the most prominent players in the AI coding space after Matan Grinberg, the CEO of Factory, accused a former board adviser of spying for his primary rival. Taking to social media on Wednesday, Grinberg claimed he fired Chris Degnan from his advisory role after discovering that
Speculative traders on the prediction market Kalshi are increasingly betting that artificial intelligence powerhouse Anthropic will announce its initial public offering before the end of the year. Interest in the company’s public debut has surged recently, with probabilities for a pre-November announcement jumping significantly from just under five percent in late September to sixteen percent
David Ellison is assembling a powerhouse leadership team as he prepares to launch one of the most ambitious media conglomerates in history. Paramount announced Wednesday that Ynon Kreiz, the outgoing CEO of Mattel, will join the organization as co-CEO following the massive merger between Paramount and Warner Bros. Discovery. The deal, valued at 111 billion